Biosimilars in Europe
This reprint examines regulatory, pricing and reimbursement issues related to the market access and uptake of off-patent biologics, biosimilars, next-generation biologics and competing innovative medicines in European countries.
Kaydedildi:
Diğer Yazarlar: | , , |
---|---|
Materyal Türü: | Elektronik Kitap Bölümü |
Dil: | İngilizce |
Baskı/Yayın Bilgisi: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
Konular: | |
Online Erişim: | DOAB: download the publication DOAB: description of the publication |
Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|
MARC
LEADER | 00000naaaa2200000uu 4500 | ||
---|---|---|---|
001 | doab_20_500_12854_96784 | ||
005 | 20230202 | ||
003 | oapen | ||
006 | m o d | ||
007 | cr|mn|---annan | ||
008 | 20230202s2023 xx |||||o ||| 0|eng d | ||
020 | |a books978-3-0365-6574-3 | ||
020 | |a 9783036565750 | ||
020 | |a 9783036565743 | ||
040 | |a oapen |c oapen | ||
024 | 7 | |a 10.3390/books978-3-0365-6574-3 |c doi | |
041 | 0 | |a eng | |
042 | |a dc | ||
072 | 7 | |a M |2 bicssc | |
072 | 7 | |a KNDP |2 bicssc | |
100 | 1 | |a Vulto, Arnold G. |4 edt | |
700 | 1 | |a Simoens, Steven |4 edt | |
700 | 1 | |a Huys, Isabelle |4 edt | |
700 | 1 | |a Vulto, Arnold G. |4 oth | |
700 | 1 | |a Simoens, Steven |4 oth | |
700 | 1 | |a Huys, Isabelle |4 oth | |
245 | 1 | 0 | |a Biosimilars in Europe |
260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2023 | ||
300 | |a 1 electronic resource (188 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
520 | |a This reprint examines regulatory, pricing and reimbursement issues related to the market access and uptake of off-patent biologics, biosimilars, next-generation biologics and competing innovative medicines in European countries. | ||
540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
546 | |a English | ||
650 | 7 | |a Medicine |2 bicssc | |
650 | 7 | |a Pharmaceutical industries |2 bicssc | |
653 | |a infliximab | ||
653 | |a etanercept | ||
653 | |a TNFα inhibitors | ||
653 | |a biologics | ||
653 | |a biosimilars | ||
653 | |a Germany | ||
653 | |a policies | ||
653 | |a incentives | ||
653 | |a uptake | ||
653 | |a market dynamics | ||
653 | |a biosimilar market | ||
653 | |a biosimilar/supply and distribution | ||
653 | |a biosimilar sustainability | ||
653 | |a Delphi technique | ||
653 | |a pricing | ||
653 | |a reimbursement | ||
653 | |a utilization | ||
653 | |a biosimilar | ||
653 | |a biological | ||
653 | |a information | ||
653 | |a education | ||
653 | |a communication | ||
653 | |a patient | ||
653 | |a Europe | ||
653 | |a adalimumab | ||
653 | |a biosimilarity assessment | ||
653 | |a quality attributes (QAs) | ||
653 | |a potentially critical quality attributes (pCQAs) | ||
653 | |a European public assessment reports (EPARs) | ||
653 | |a clinical governance | ||
653 | |a Spain | ||
653 | |a barriers | ||
653 | |a regulatory | ||
653 | |a review | ||
653 | |a approval | ||
653 | |a clinical | ||
653 | |a queries | ||
653 | |a regulatory science | ||
653 | |a budget impact analysis | ||
653 | |a savings | ||
653 | |a pharmaceutical spending | ||
653 | |a cost containment | ||
653 | |a reference biological | ||
653 | |a competitive market | ||
653 | |a Belgium | ||
653 | |a trastuzumab | ||
653 | |a intravenous | ||
653 | |a subcutaneous | ||
653 | |a HER2-positive breast cancer | ||
653 | |a drug costs | ||
653 | |a healthcare costs | ||
653 | |a cost simulation | ||
653 | |a tender | ||
653 | |a procurement | ||
653 | |a off-patent | ||
653 | |a award criteria | ||
653 | |a switching | ||
653 | |a interchangeability | ||
653 | |a sustainability | ||
653 | |a competition | ||
653 | |a n/a | ||
856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/6730 |7 0 |z DOAB: download the publication |
856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/96784 |7 0 |z DOAB: description of the publication |